About this source
- Kind
- Research
- Design
- Narrative review
- Primary or secondary
- secondary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
A peer-reviewed summary of the drug's development, not a regulator's record. The abstract says 'USA' without naming the agency and gives no exact day. Full text not read.
Cited in
Other conditions under study
Elamipretide · Research finding
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.